IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v39y2021i9d10.1007_s40273-021-01057-y.html
   My bibliography  Save this article

Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

Author

Listed:
  • Becky Pennington

    (University of Sheffield)

  • Abualbishr Alshreef

    (University of Sheffield)

  • Laura Flight

    (University of Sheffield)

  • Andrew Metry

    (University of Sheffield)

  • Edith Poku

    (University of Sheffield)

  • Philip Hykin

    (NIHR Moorfields Biomedical Research Centre)

  • Sobha Sivaprasad

    (NIHR Moorfields Biomedical Research Centre)

  • A. Toby Prevost

    (King’s College London)

  • Joana C. Vasconcelos

    (King’s College London)

  • Caroline Murphy

    (King’s College London)

  • Joanna Kelly

    (King’s College London)

  • Yit Yang

    (Wolverhampton Eye Infirmary)

  • Andrew Lotery

    (University of Southampton)

  • Michael Williams

    (Queen’s University of Belfast)

  • John Brazier

    (University of Sheffield)

Abstract

No abstract is available for this item.

Suggested Citation

  • Becky Pennington & Abualbishr Alshreef & Laura Flight & Andrew Metry & Edith Poku & Philip Hykin & Sobha Sivaprasad & A. Toby Prevost & Joana C. Vasconcelos & Caroline Murphy & Joanna Kelly & Yit Yang, 2021. "Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study," PharmacoEconomics, Springer, vol. 39(9), pages 1099-1099, September.
    • Handle: RePEc:spr:pharme:v:39:y:2021:i:9:d:10.1007_s40273-021-01057-y
    DOI: 10.1007/s40273-021-01057-y
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-021-01057-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-021-01057-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:39:y:2021:i:9:d:10.1007_s40273-021-01057-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.